CAL
CDNA icon

Capital Advisors Ltd’s CareDx CDNA Stock Holding History

Capital Advisors Ltd’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5
Closed – – 1037
2022
Q1 		$0 Buy
+5
New +$195 ﹤0.01% 931

Other funds holding CDNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Capital Advisors Ltd's CDNA Position: Q2 2022 in Review

Capital Advisors Ltd sold out of CareDx (CDNA) in Q2 2022, closing a stake of 5 shares.

Capital Advisors Ltd first reported a position in CDNA in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 184 funds tracked by Wall St. Rank hold CDNA as of Q2 2022.

  • Capital Advisors Ltd reported no remaining CareDx position as of Q2 2022 after selling out during the quarter.
  • Capital Advisors Ltd sold 5 CareDx shares in Q2 2022.
  • Capital Advisors Ltd first reported a position in CareDx in Q1 2022 and held it in 1 quarter.
  • Capital Advisors Ltd's CareDx position peaked at $0 in Q1 2022.
  • 184 funds tracked by Wall St. Rank held CareDx as of Q2 2022.

Based on Capital Advisors Ltd's 13F filing for Q2 2022, filed 5 Aug 2022.